Woo, E S; Rice, R L; Lazo, J S (1999) Cell cycle dependent subcellular distribution of Cdc25B subtypes. Oncogene 18:2770-6
|
Kondo, Y; Yanagiya, T; Himeno, S et al. (1999) Simian virus 40-transformed metallothionein null cells showed increased sensitivity to cadmium but not to zinc, copper, mercury or nickel. Life Sci 64:PL145-50
|
Fabisiak, J P; Tyurin, V A; Tyurina, Y Y et al. (1999) Redox regulation of copper-metallothionein. Arch Biochem Biophys 363:171-81
|
Yang, Y Y; Robbins, P D; Lazo, J S (1998) Differential transactivation of human metallothionein-IIa in cisplatin-resistant and -sensitive cells. Oncol Res 10:85-98
|
Koldamova, R P; Lefterov, I M; Gadjeva, V G et al. (1998) Essential binding and functional domains of human bleomycin hydrolase. Biochemistry 37:2282-90
|
Fabisiak, J P; Kagan, V E; Tyurina, Y Y et al. (1998) Paraquat-induced phosphatidylserine oxidation and apoptosis are independent of activation of PLA2. Am J Physiol 274:L793-802
|
Fabisiak, J P; Tyurina, Y Y; Tyurin, V A et al. (1998) Random versus selective membrane phospholipid oxidation in apoptosis: role of phosphatidylserine. Biochemistry 37:13781-90
|
Woo, E S; Lazo, J S (1997) Nucleocytoplasmic functionality of metallothionein. Cancer Res 57:4236-41
|
Rice, R L; Rusnak, J M; Yokokawa, F et al. (1997) A targeted library of small-molecule, tyrosine, and dual-specificity phosphatase inhibitors derived from a rational core design and random side chain variation. Biochemistry 36:15965-74
|
Lazo, J S; Li, T; Woo, E S et al. (1997) Chemical synthesis and biological activity of a novel fluorescent etoposide derivative. Biochem Pharmacol 53:715-22
|
Showing the most recent 10 out of 19 publications